Carregant...

The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy

PURPOSE: Constructed from a theoretical framework, the coordinated undermining of survival paths in glioblastoma (GBM) is a combination of nine drugs approved for non-oncological indications (CUSP9; aprepitant, auranofin, captopril, celecoxib, disulfiram, itraconazole, minocycline, quetiapine, and s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer Res Clin Oncol
Autors principals: Skaga, Erlend, Skaga, Ida Ø., Grieg, Zanina, Sandberg, Cecilie J., Langmoen, Iver A., Vik-Mo, Einar O.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527541/
https://ncbi.nlm.nih.gov/pubmed/31028540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-019-02920-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!